Track Cardax's common stock ($800) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Cardax (CDXI) currently reports a common stock of $800 as of March 2021. That compares with $760 in the prior-year period — up 5.2% year over year. Use the charts on this page to explore Cardax's common stock history and peer comparisons.
Cardax's common stock increased from $760 to $800 — a 5.2% year-over-year increase (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cardax reported $800 in common stock as of March 2021. That compares with $760 in the prior-year period — up 5.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $800, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cardax, and consider following CDXI for alerts when major investors trade the stock.
Cardax is classified in the Healthcare sector. On common stock, it currently shows $800. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDXI with unrelated industries.